Aimei Health Technology (NASDAQ:AFJK) Sees Unusually-High Trading Volume – Here’s Why

Shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) saw unusually-high trading volume on Tuesday . Approximately 624,015 shares traded hands during mid-day trading, an increase of 489% from the previous session’s volume of 105,883 shares.The stock last traded at $102.7510 and had previously closed at $43.65.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Aimei Health Technology Stock Up 99.2%

The company has a 50 day moving average price of $20.29 and a 200-day moving average price of $14.43. The company has a market cap of $532.14 million, a price-to-earnings ratio of 459.61 and a beta of 0.03.

Aimei Health Technology (NASDAQ:AFJK) last posted its earnings results on Tuesday, November 18th. The company reported $0.06 EPS for the quarter.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Crossingbridge Advisors LLC bought a new stake in Aimei Health Technology during the 2nd quarter worth approximately $2,147,000. Berkley W R Corp grew its holdings in Aimei Health Technology by 23.6% during the second quarter. Berkley W R Corp now owns 425,361 shares of the company’s stock worth $4,704,000 after buying an additional 81,235 shares in the last quarter. Clear Street Group Inc. bought a new stake in Aimei Health Technology during the third quarter worth $691,000. Clear Street LLC raised its position in Aimei Health Technology by 63.8% in the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after buying an additional 15,399 shares during the last quarter. Finally, Wellspring Financial Advisors LLC bought a new position in Aimei Health Technology during the 2nd quarter valued at $133,000. 45.58% of the stock is owned by institutional investors.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.